Published February 28, 2026 | Version v1
Journal article Open

Role of Antimicrobial Therapy in Periodontics and Peri-Implantitis - A Review

Authors/Creators

  • 1. International Journal of Dental Science and Innovative Research (IJDSIR)

Description

Abstract

Periodontal disease encompasses inflammatory conditions affecting the gingiva, periodontal ligament, cementum, and alveolar bone1. It is initiated by a complex microbial biofilm and influenced by host immune responses and environmental factors2. Although scaling and root planing (SRP) remains the cornerstone of periodontal therapy3, adjunctive antimicrobial therapy is indicated in certain clinical situations to enhance clinical outcomes4. Locally or systemically delivered antimicrobial agents suppress periodontal pathogens, reduce inflammation, and promote periodontal healing5. This article reviews the rationale, classification, indications, and mechanisms of action, clinical applications, advantages, limitations, and adverse effects of antimicrobial therapy in periodontics, with an emphasis on evidence-based practice.

Files

ASMITA.pdf

Files (1.0 MB)

Name Size
md5:1f69b4391b71219ef030eb9ae3e40d30
1.0 MB Preview Download

Additional details

Software

Repository URL
https://www.ijdsir.com/issue/archive_issue/84/Issue%20%20%201%20%20February

References

  • 1. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;3:17038. doi: 10.1038/nrdp.2017.38 2. Hajishengallis G. Periodontitis: from microbial immune subversion to systemic inflammation. Nat Rev Immunol.2015;15(1):30-44. doi: 10.1038/ nri3785 3. Cobb CM. Clinical significance of non-surgical periodontal therapy: an evidence-based perspective of scaling and root planing. J Clin Periodontol. 2002;29 Suppl 2:6-16. doi: 10.1034/j.1600-051x. 29.s2.4.x 4. Smiley CJ, Tracy SL, Abt E, et al. Systematic review and meta-analysis on the nonsurgical treatment of chronic periodontitis by means of scaling and root planing with or without adjuncts. J Am Dent Assoc. 2015;146(7):508-524. doi: 10.1016/ j.adaj. 2015.01.028 5. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000. 2002;28:106-176. doi: 10.1034/j.1600-0757. 2002. 280106.x 6. Socransky SS, Haffajee AD. Periodontal microbial ecology. Periodontol 2000. 2005;38:135-187. doi:10.1111/j.1600-0757.2005.00107.x 7. Socransky SS, Haffajee AD, Cugini MA, Smith C, Kent RL Jr. Microbial complexes in subgingival plaque. J Clin Periodontol. 1998;25(2):134-144. doi: 10.1111/j.1600-051x.1998.tb02419.x 8. How KY, Song KP, Chan KG. Porphyromonas gingivalis: An Overview of Periodontopathic Pathogen below the Gum Line. Front Microbiol. 2016;7:53. doi: 10.3389/fmicb.2016.00053 9. Slots J. Selection of antimicrobial agents in periodontal therapy. J Periodontal Res. 2002;37(5):389-398. doi:10.1034/j.1600-0765. 2002. 00004.x 10. Goodson JM. Antimicrobial strategies for treatment of periodontal diseases. Periodontol 2000. 1994;5:142-168.doi: 10.1111/j.1600-0757. 1994. tb00023.x 11. Carranza FA Jr, Saglie FR, Newman MG, Valentin PL. Scanning and transmission electron microscopic study of tissue-invading microorganisms in localized juvenile periodontitis. J Periodontol. 1983;54 (10):598-617. doi: 10.1902/jop.1983.54.10.598 12. Magnusson I, Lindhe J, Yoneyama T, Liljenberg B. Recolonization of a subgingival microbiota following scaling in deep pockets. J Clin Periodontol. 1984;11(3):193-207. doi: 10.1111/j.1600-051x. 1984. tb01318.x 13. Rams TE, Slots J. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol. 1996;23(3 Pt 2):201-211. doi: 10.1111/j.1600-051x.1996.tb02076.x 14. Greenstein G. Position paper: The role of supra- and subgingival irrigation in the treatment of periodontal diseases. J Periodontol. 2005;76(11):2015-2027. doi: 10.1902/jop.2005.76.11.2015 15. Greenstein G, Polson A. The role of local drug delivery in the management of periodontal diseases: a comprehensive review. J Periodontol. 1998; 69(5):507-520. doi: 10.1902/jop.1998.69.5.507 16. Jain N, Jain GK, Javed S, et al. Recent approaches for the treatment of periodontitis. Drug Discov Today.2008;13(21-22):932-943. doi: 10.1016/j. drudis.2008.07.010 17. American Academy of Periodontology. Position paper: systemic antibiotics in periodontics. J Periodontol.2004;75(11):1553-1565. doi: 10.1902/ jop.2004.75.11.1553 18. Feres M, Figueiredo LC, Soares GM, Faveri M. Systemic antibiotics in the treatment of periodontitis.Periodontol 2000. 2015;67(1):131-186. doi: 10.1111/prd.12075 19. Jones CG. Chlorhexidine: is it still the gold standard? Periodontol 2000. 1997;15:55-62. doi:10.1111/ j.1600-0757.1997.tb00105.x 20. Gilbert P, Moore LE. Cationic antiseptics: diversity of action under a common epithet. J Appl Microbiol.2005;99(4):703-715. doi: 10.1111/j.1365-2672.2005.02664.x 21. Jeffcoat MK, Bray KS, Ciancio SG, et al. Adjunctive use of a subgingival controlled-release chlorhexidine chipreduces probing depth and improves attachment level compared with scaling and root planing alone. JPeriodontol. 1998;69(9):989-997. doi: 10.1902/ jop.1998.69.9.989 22. Soskolne WA, Heasman PA, Stabholz A, et al. Sustained local delivery of chlorhexidine in the treatment ofperiodontitis: a multi-center study. J Periodontol. 1997;68(1):32-38. doi: 10.1902/ jop.1997.68.1.32 23. Matesanz-Pérez P, García-Gargallo M, Figuero E, et al. A systematic review on the effects of localantimicrobials as adjuncts to subgingival debridement, compared with subgingival debridement alone, in thetreatment of chronic periodontitis. J Clin Periodontol. 2013;40(3):227-241. doi: 10.1111/jcpe.12026 24. Pavia M, Nobile CG, Angelillo IF. Meta-analysis of local tetracycline in treating chronic periodontitis. JPeriodontol. 2003;74(6):916-932. doi: 10.1902/ jop.2003.74.6.916 25. Flötra L, Gjermo P, Rölla G, Waerhaug J. Side effects of chlorhexidine mouth washes. Scand J Dent Res.1971;79(2):119-125. doi: 10.1111/j.1600-0722.1971.tb01995.x 26. Brecx MC, Macdonald LL, Legary K, Cheang M, Forgay MG. Long-term effects of Meridol and chlorhexidinemouthrinses on plaque, gingivitis, staining, and bacterial vitality. J Dent Res. 1993;72(8):1194-1197. doi:10.1177/ 0022034593 0720080501 27. Chopra I, Roberts M. Tetracycline antibiotics: mode of action, applications, molecular biology, andepidemiology of bacterial resistance. Microbiol Mol Biol Rev. 2001;65(2):232-260. doi:10. 1128/MMBR.65.2.232-260.2001 28. Golub LM, Lee HM, Ryan ME, Giannobile WV, Payne J, Sorsa T. Tetracyclines inhibit connective tissuebreakdown by multiple non-antimicrobial mechanisms. Adv Dent Res. 1998;12(2):12-26. doi: 10.1177/08959374980120010501 29. Gordon JM, Walker CB, Murphy JC, Goodson JM, Socransky SS. Tetracycline: levels achievable in gingivalcrevice fluid and in vitro effect on subgingival organisms. Part 1. Concentrations in crevicular fluid after repeated doses. J Periodontol. 1981;52(10):609-612. doi: 10.1902/ jop.1981. 52. 10.609 30. Goodson JM, Cugini MA, Kent RL, et al. Multicenter evaluation of tetracycline fiber therapy: II. Clinical response. J Periodontal Res. 1991;26(4):371-379. doi: 10.1111/j.1600-0765. 1991. tb02072.x 31. Rudhart A, Purucker P, Kage A, Hopfenmüller W, Bernimoulin JP. Local metronidazole application inmaintenance patients. Clinical and microbiological evaluation. J Periodontol. 1998;69(10):1148-1154. doi:10.1902/jop.1998.69.10.1148 32. Heasman PA, Heasman L, Stacey F, McCracken GI. Local delivery of chlorhexidine gluconate (PerioChip) inperiodontal maintenance patients. J Clin Periodontol. 2001;28(1):90-95. doi:10.1034/ j.1600-051x.2001.280113.x 33. Garrett S, Johnson L, Drisko CH, et al. Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis. JPeriodontol. 1999;70(5):490-503. doi: 10.1902/jop.1999.70.5.490 34. Garrett S, Adams DF, Bogle G, et al. The effect of locally delivered controlled-release doxycycline or scalingand root planing on periodontal maintenance patients over 9 months. J Periodontol. 2000;71(1):22-30. doi:10.1902/jop.2000.71.1.22 35. Preshaw PM, Hefti AF, Jepsen S, Etienne D, Walker C, Bradshaw MH. Subantimicrobial dose doxycycline as adjunctive treatment for periodontitis. A review. J Clin Periodontol. 2004;31(9):697-707. doi:10.1111/j.1600-051X.2004.00558.x 36. Freeman CD, Klutman NE, Lamp KC. Metronidazole. A therapeutic review and update. Drugs.1997;54(5):679-708. doi: 10.2165/00003495-199754050-00003 37. Pedrazzoli V, Kilian M, Karring T. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% gel and scaling in the treatment of adult periodontitis. J Clin Periodontol. 1992;19(9 Pt 1):715-722. doi: 10.1111/j.1600-051x.1992.tb02160.x 38. Stelzel M, Florès-de-Jacoby L. Topical metronidazole application compared with subgingival scaling. A clinical and microbiological study on recall patients. J Clin Periodontol. 1996;23(1):24-29. doi: 10.1111/j.1600-051x. 1996. tb00499.x 39. Williams RC, Paquette DW, Offenbacher S, et al. Treatment of periodontitis by local administration of minocycline microspheres: a controlled trial. J Periodontol. 2001;72(11):1535-1544. doi: 10.1902/ jop.2001.72.11.1535 40. Goodson JM, Gunsolley JC, Grossi SG, et al. Minocycline HCl microspheres reduce red-complex bacteria in periodontal disease therapy. J Periodontol. 2007;78(8):1568-1579. doi: 10.1902/jop. 2007. 060488 41. Killeen AC, Harn JA, Erickson LR, Yu F, Reinhardt RA. Local minocycline effect on inflammation and clinical attachment during periodontal maintenance: randomized clinical trial. J Periodontol. 2016;87 (10):1149-1157.doi: 10.1902/jop.2016.150551 42. van Winkelhoff AJ, Rams TE, Slots J. Systemic antibiotic therapy in periodontics. Periodontol 2000.1996;10:45-78. doi: 10.1111/j.1600-0757.1996. tb00068.x 43. Slots J, Ting M. Systemic antibiotics in the treatment of periodontal disease. Periodontol 2000.2002; 28:106-176. doi: 10.1034/j.1600-0757.2002. 280106.x 44. Slots J. Systemic antibiotics in periodontics. J Periodontol. 2004;75(11):1553-1565. doi:10.1902/ jop.2004.75.11.1553 45. Löe H, Schiött CR. The effect of mouthrinses and topical application of chlorhexidine on the development ofdental plaque and gingivitis in man. J Periodontal Res. 1970;5(2):79-83. doi:10.1111/ j.1600-0765.1970.tb01842.x 46. Herrera D, Alonso B, León R, Roldán S, Sanz M. Antimicrobial therapy in periodontitis: the use of systemic antimicrobials against the subgingival biofilm. J Clin Periodontol. 2008;35(8 Suppl):45-66. doi:10.1111/j.1600-051X.2008.01260.x 47. Winkel EG, Van Winkelhoff AJ, Timmerman MF, Vangsted T, Van der Velden U. Amoxicillin plus metronidazolein the treatment of adult periodontitis patients. A double-blind placebo-controlled study. J Clin Periodontol.2001;28(4):296-305. doi: 10.1034/ j.1600-051x.2001.028004296.x 48. Kong KF, Schneper L, Mathee K. Beta-lactam antibiotics: from antibiosis to resistance and bacteriology. APMIS. 2010;118(1):1-36. doi: 10.1111/j.1600-0463.2009.02563.x 49. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012;39(3):284-294. doi: 10.1111/ j.1600-051X.2011.01795.x 50. Haffajee AD, Socransky SS, Gunsolley JC. Systemic anti-infective periodontal therapy. A systematic review.Ann Periodontol. 2003;8(1):115-181. doi: 10.1902/annals.2003.8.1.115 51. Gomi K, Yashima A, Iino F, et al. Drug concentration in inflamed periodontal tissues after systemically administered azithromycin. J Periodontol. 2007;78(5):918-923. doi: 10.1902/ jop. 2007.060301 52. Rams TE, Degener JE, van Winkelhoff AJ. Antibiotic resistance in human chronic periodontitis microbiota. J Periodontol. 2014;85(1):160-169. doi: 10.1902/jop.2013.130142 53. Walker CB. The acquisition of antibiotic resistance in the periodontal microflora. Periodontol 2000. 1996;10:79-88. doi: 10.1111/j.1600-0757. 1996. tb00069.x 54. Rams TE, Degener JE, van Winkelhoff AJ. Prevalence of β-lactamase-producing bacteria in human periodontitis. J Periodontal Res. 2013;48 (4):493-499. doi: 10.1111/jre.12031 55. Slots J, Rams TE. Antibiotics in periodontal therapy: advantages and disadvantages. J Clin Periodontol. 1990;17(7 Pt 2):479-493. PMID: 2202743 56. Ferrer MD, López-López A, Nicolescu T, et al. A prospective study to assess the antibiotic resistance patterns of bacterial species inhabiting the oral cavity after amoxicillin exposure. Int J Antimicrob Agents. 2013;42(5):465-469. doi: 10.1016/ j.ijantimicag. 2013.07.005 57. Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30 years of maintenance. J Clin Periodontol. 2004;31(9):749-757. doi: 10.1111/ j.1600-051X. 2004.00563.x 58. Allaker RP, Memarzadeh K. Nanoparticles and the control of oral infections. Int J Antimicrob Agents. 2014;43(2):95-104. doi: 10.1016/ j.ijantimicag. 2013.11.002 59. Teughels W, Newman MG, Coucke W, et al. Guiding periodontal pocket recolonization: a proof of concept. J Dent Res. 2007;86(11):1078-1082. doi: 10.1177/154405910708601111 60. Colombo AP, Magalhães CB, Hartenbach FA, do Souto RM, da Silva-Boghossian CM. Periodontal-disease-associated biofilm: A reservoir for pathogens of medical importance. Microb Pathog. 2016;94:27-34. doi: 10.1016/j.micpath.2015.09.009 61. Medaiah S, Srinivas M, Melath A, Girish S, Polepalle T, Dasari AB. Chlorhexidine chip in the treatment of chronic periodontitis - a clinical study. J Clin Diagn Res. 2014 Jun;8(6):ZC22-5. doi: 10.7860/JCDR/2014/8808.4477. Epub 2014 Jun 20. PMID: 25121059; PMCID: PMC4129267. 62. Pant VA, Aamir M, Maurya DK. Tetracycline fiber: A drug in your pocket [Internet]. IP Int J Periodontol Implantol. 2022 [cited 2026 Feb 03];7(1):27-32. Available from: https://doi.org/ 10.18231/ j.ijpi. 2022.006 63. Dorairaj, Jayachandran & Jayachandran, Drsunantha. (2017). Effect of a controlled-release device containing doxycycline hyclate in the treatment of chronic periodontitis-a clinical and microbiological study. european journal of pharmaceutical and medical research. 4. 235-44. 64. Gandhi UH, Vyas SD, Mane V, Patel SN, Patadiya HH, Kumar S, Haque M. The Effectiveness of Metronidazole as a Localized Drug Delivery System in the Treatment of Periodontal Diseases: A Narrative Review. Cureus. 2025 Mar 13;17 (3):e80547. doi: 10.7759/cureus.80547. PMID: 40091900; PMCID: PMC11907172. 65. Gopinath V, Ramakrishnan T, Emmadi P, Ambalavanan N, Mammen B, Vijayalakshmi. Effect of a controlled release device containing minocycline microspheres on the treatment of chronic periodontitis: A comparative study. J Indian Soc Periodontol. 2009 May;13(2):79-84. doi: 10.4103/ 0972-124X.55844. PMID: 20407655; PMCID: PMC2847129. 66. Belibasakis GN, Manoil D. Microbial community-driven etiopathogenesis of peri-implantitis. J Dent Res. 2020;99(11):1231–1239. 67. Wisdom EC, Zhou Y, Chen C, Tamerler C, Snead ML. Mitigation of peri-implantitis by rational design of bifunctional peptides with antimicrobial properties. ACS Biomater Sci Eng. 2020;6(5):2682–2695. 68. Berglundh T, Armitage G, Araujo MG, et al. Peri-implant diseases and conditions: Consensus report of Workgroup 4 of the 2017 World Workshop. J Clin Periodontol. 2018;45(Suppl20):S286-S291. 69. Figuero E, Graziani F, Sanz I, Herrera D, Sanz M. Management of peri-implant mucositis and peri-implantitis. J Clin Periodontol. 2014;41(Suppl 15): S152-S157. 70. Renvert S, Polyzois I. Treatment of peri-implantitis. Clin Oral Implants Res. 2015;26(Suppl 11):S105-S107. 71. Herrera D, Sanz M, Jepsen S, Needleman I, Roldán S. A systematic review on systemic antimicrobials in periodontitis. J Clin Periodontol. 2002;29(Suppl 3):S136-S159. 72. Soukos NS, Goodson JM. Photodynamic therapy in the control of oral biofilms. Periodontol 2000. 2011 Feb;55(1):143-66. doi: 10.1111/j.1600-0757.2010. 00346.x. PMID: 21134233. 73. Al Rifaiy MQ, Qutub OA, Alasqah MN, Al-Sowygh ZH, Mokeem SA, Alrahlah A. Effectiveness of adjunctive antimicrobial photodynamic therapy in reducing peri-implant inflammatory response in individuals vaping electronic cigarettes: A randomized controlled clinical trial. Photo diagnosis Photodyn Ther. 2018 Jun;22:132-136. doi: 10. 1016/j.pdpdt.2018.03.002. Epub 2018 Mar 15. PMID: 29550362. 74. Rai MK, Deshmukh SD, Ingle AP, Gade AK. Silver nanoparticles: the powerful nanoweapon against multidrug-resistant bacteria. J Appl Microbiol. 2012 May;112(5):841-52. doi: 10.1111/j.1365-2672.2012. 05253.x. Epub 2012 Mar 28. PMID: 22324439. 75. Flichy-Fernández AJ, Ata-Ali J, Alegre-Domingo T, Candel-Martí E, Ata-Ali F, Palacio JR, Peñarrocha-Diago M. The effect of orally administered probiotic Lactobacillus reuteri-containing tablets in peri-implant mucositis: a double-blind randomized controlled trial. J Periodontal Res. 2015 Dec;50 (6):775-85. doi: 10.1111/jre.12264. Epub 2015 Feb 25. PMID: 25712760. 76. Golub LM, Lee HM, Stoner JA, Sorsa T, Reinhardt RA, Wolff MS, Ryan ME, Nummikoski PV, Payne JB. Sub antimicrobial-dose doxycycline modulates gingival crevicular fluid biomarkers of periodontitis in postmenopausal osteopenia women. J Periodontal. 2008 Aug;79(8):1409-18. doi: 10.1902/ jop.2008. 070623. PMID: 18672990; PMCID: PMC2553351. 77. El-Sharkawy H, Aboelsaad N, Eliwa M, Darweesh M, Alshahat M, Kantarci A, Hasturk H, Van Dyke TE. Adjunctive treatment of chronic periodontitis with daily dietary supplementation with omega-3 Fatty acids and low-dose aspirin. J Periodontol. 2010 Nov;81(11):1635-43. doi: 10.1902/jop.2010.090628. Epub 2010 Jun 23. PMID: 20572767. 78. Binderman I, Adut M, Yaffe A. Effectiveness of local delivery of alendronate in reducing alveolar bone loss following periodontal surgery in rats. J Periodontol. 2000 Aug;71(8):1236-40. doi: 10. 1902/jop.2000.71.8.1236. PMID: 10972639.